Recently, the Tianjin Municipal Bureau of Industry and Information Technology publicly announced the list of the second batch of Tianjin specialized, refined, distinctive, and innovative "seed" enterprises for 2023, and ProteinT Medical Laboratory (Tianjin Baikang Hexin Medical Laboratory), the independent clinical trial execution window under ProteinT, was successfully selected.
This recognition of ProteinT Medical Laboratory, following ProteinT's winning of the "Specialized, Refined, Distinctive, and Innovative SME" title (Good News | A Good Start! ProteinT Awarded the "Specialized, Refined, Distinctive, and Innovative SME" Certification), represents another full recognition by the state and the market in terms of core technology, innovation capability, management level, and growth potential. In the future, ProteinT will continue to strengthen technological research and development, enhance independent innovation capability, continuously boost core competitiveness, and continue to delve deeply into the fields of protein and other multi-omics, providing clinical doctors and patients with even better products and services.
About Tianjin Baikang Hexin Medical Laboratory
Tianjin Baikang Hexin Medical Laboratory is the independent clinical trial execution window under ProteinT. It is a national high-tech enterprise and a for-profit medical institution approved by the Health Commission, equipped with an Illumina NextSeq 500 sequencing system, Thermo Fisher Q-Exactive+/HF, AB SCIEX 4500 mass spectrometry system, and Bruker Avance III IVDr nuclear magnetic resonance spectrometer detection platform, with a total value of over 90 million yuan. It has cumulatively served over a hundred tertiary hospitals and research institutes, with a sample volume of over 100,000 cases.
About Specialized, Refined, Distinctive, and Innovative "Seed" Enterprises
"Specialized, Refined, Distinctive, and Innovative" is a major project implemented by the state to guide small and medium-sized enterprises along the development path of "specialization, refinement, distinctiveness, and novelty," enhance independent innovation capability and core competitiveness, and continuously improve the development quality and level of SMEs. Specialized, refined, distinctive, and innovative enterprises hold an important position in China's economic development, with leading products having a high market share in their domestic niche industries and playing an important role in "shoring up weak links" and "filling gaps." Specialized, refined, distinctive, and innovative "seed" enterprises refer to SMEs that have formed an initial scale and possess considerable potential in a niche field, cultivated as a reserve pool for specialized, refined, distinctive, and innovative SMEs.
